What happened
HEM Pharma disclosed a supply contract with HEM Pharma Japan Inc., worth US$4.98M, about 47.68% of its recent annual revenue, running through Feb 2027.
For context, this single contract equals about 47.68% of the company's most recent annual revenue.
| Counterparty | HEM Pharma Japan Inc. |
|---|---|
| Contract value | US$4.98M |
| vs. recent revenue | 47.68% |
| Through | Feb 2027 (from Feb 2026) |
| Filed | 2026-02-24, Supply contract signed |
| Source | DART rcept 20260224901391 → open original filing |
Source: DART. Information only, not investment advice.